Topic resource collection
Approved comparison material connected to this topic.
83 resourcesRead both sides
Before selecting a peptide for anxiety research protocols, understanding the mechanistic, temporal, and logistical differences across compounds is essential. The following table compares the three most studied peptides in anxiety…
GHRP-2 Ghrelin receptor agonist; stimulates pulsatile GH release GH/IGF-1 axis Muscle mass, grip strength 100–300 mcg SC, 1–2x daily Strong evidence for muscle preservation; requires consistent dosing to maintain GH pulse pattern…
Selank GABA-A modulation via leucine-enkephalin pathway 15–30 minutes (intranasal) 12 weeks (no tolerance) Acute fear response, GABAergic pathway mapping Gold standard for non-sedating anxiolytic mechanism studies. Reproducible a…
DSIP Binds delta sleep-inducing factor receptors in hypothalamus None. Increases slow-wave sleep without affecting REM latency or percentage 0.5–2 mg subcutaneous before sleep Oxidises rapidly above 8°C; lyophilised form stable 2…
CJC-1295 (with DAC) GHRH analog. Extends endogenous GH half-life from 7 minutes to 6–8 days, amplifies pulse amplitude Pituitary GHRH receptors 1–2mg weekly (subcutaneous) 4–6 weeks for visceral adipose reduction measurable via i…
BPC-157 Growth hormone receptor upregulation, VEGF pathway activation 0–72 hours post-injury (acute phase) 28–30 days at 2–8°C 55–62% faster tendon-to-bone healing (University of Zagreb, 2023) Best suited for acute injury models …
For research peptides, request batch-specific COAs showing HPLC purity (should be 98%+) and mass spectrometry confirmation of molecular identity. For pharmaceutical-grade or compounded peptides, verify the pharmacy holds appropri…
Regulatory Framework Research chemicals FDA drug approval (NDA) FDA compounding regulations (503A/503B) Prescription Required No Yes Intended Use Laboratory research Patient treatment Patient treatment (custom) Quality Standard T…
Safety considerations differ significantly when evaluating research peptides vs prescription peptides, primarily because of the different evidence frameworks and oversight structures involved. Research peptide safety data comes p…
Cost is one of the most significant practical distinctions between research peptides vs prescription peptides. Understanding the pricing structures helps researchers and institutions plan budgets appropriately. Research peptide p…
The regulatory landscape governing research peptides vs prescription peptides is fundamentally different at every level. Understanding these frameworks helps researchers make informed sourcing decisions in 2026. Research peptide …
The decision between research peptides vs prescription peptides ultimately depends on the specific use case, regulatory context, and intended application. This comparison framework helps researchers make informed decisions. For p…
ARA-290 (reference) Innate repair receptor activation IRR/CD131 Broad (neural, vascular, epithelial) 3–5 hours 2–8°C refrigerated 1–10 mg/kg BPC-157 VEGF receptor modulation + NO stabilization Angiogenesis, fibroblast migration G…
Tirzepatide Dual GLP-1/GIP agonist GLP-1R, GIPR ~5 days Metabolic research, insulin sensitivity studies Strongest metabolic efficacy data among dual agonists; 20.9% mean weight reduction in SURMOUNT-1 trial Survodutide Dual GLP-1…
P21 operates through an entirely different neurotrophic pathway. It is a synthetic derivative of activity-dependent neurotrophic factor (ADNF), a peptide endogenously released by astrocytes in response to vasoactive intestinal pe…
| Peptide | Primary Mechanism | Optimal Administration | Effective Dose Range (Rodent Models) | BBB Penetration Method | Unique Research Application | Professional Assessment ||—|—|—|—|—|—|| Dihexa | HGF/c-Met receptor potentiati…
This table compares the primary IGF-1 LR3 alternatives based on mechanism, half-life, dosing frequency, and research application suitability. Use this to match peptide characteristics to your specific protocol requirements. MK-67…
Carbetocin Selective oxytocin receptor agonist with deamino modification ~30 minutes Reproductive neuroscience, maternal bonding models Resistant to aminopeptidase degradation; 6–15× longer plasma exposure than oxytocin Gold stan…
FOXO4-DRI functions as a senolytic. It induces apoptosis in senescent cells by blocking the FOXO4 transcription factor from binding to p53, which otherwise prevents cell death in cells that have exited the cell cycle but remain m…
Semax BDNF upregulation, hippocampal neurogenesis via ACTH(4-10) signaling 50–300 µg/kg intranasal, daily for 7–14 days Forced swim test, learned helplessness, Morris water maze 7–10 days (chronic administration) Best choice for …